Remove Manufacturing Remove Pharma Remove Pharmaceutical research Remove Prescription
article thumbnail

And so pharma profiteers again

World of DTC Marketing

This comes at a time when industry fart sniffing publications like Fierce Pharma report “pharma continues to shine under the pandemic spotlight. Pharma earned a solid No. Best of all are patients in the US, where prices are highest, and with chronic conditions requiring repeat prescriptions.

Pharma 191
article thumbnail

Entry-Level Pharma Sales: It's More Than Just a Job Search (Here's Why)

Contrarian Sales Techniques

In this blog post, I’d like to go deeper into that world, and not just finding an entry-level position in a Pharma company. Let’s look at the exciting possibilities, essential skills, and valuable resources that can prepare you for success with the entry-level pharmaceutical sales. This could include therapeutic areas (e.g.,

Sales 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PhRMA is going to have to write some big checks

World of DTC Marketing

SUMMARY: President Biden wants to lower prescription drug costs. Even though prescription drug costs are only $.11 More new drugs are being developed by smaller biotechs who big pharma companies are acquiring as their drug candidates move through clinical trials. It is coming a lot faster now, and pharma has to be ready.

article thumbnail

New legislation is a great first step to lower drug prices

World of DTC Marketing

It’s a collection of measures meant to bring down prices slowly and on targeted drugs, and pharma is already complaining. Most adults – across partisans – don’t believe high drug prices are needed for drug companies to invest in new research instead agreeing that “even if U.S. Big Pharma remains the cash king. Why did it happen?

article thumbnail

US Democrats’ blockbuster budget bill could spell big changes for drug prices

pharmaphorum

In addition to the climate provisions, however, the bill has a significant effect on prescription drug prices, and according to reports neither Manchin nor Sinema is objecting to these provisions, which are similar but not identical to the ones in the Build Back Better plan which previously passed in the House of Representatives.